Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| _version_ | 1867016858321813504 |
|---|---|
| author | Michael O. Killian Callie W. Little Sonnie E. Mayewski |
| author_facet | Michael O. Killian Callie W. Little Sonnie E. Mayewski Michael O. Killian Callie W. Little Sonnie E. Mayewski |
| collection | Wiley Open Access |
| contents | Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients Michael O. Killian Callie W. Little Sonnie E. Mayewski Clinical Transplantation ABSTRACTIntroductionLimited research has explored immunosuppressant medication adherence over time in pediatric transplant patients, who often struggle with posttransplant regimen adherence, resulting in poor outcomes.MethodsThis study investigated the longitudinal growth in immunosuppressive medication levels following transplantation. Medication level variability index (MLVI) scores from tacrolimus blood levels of pediatric organ transplant recipients at a major medical center were analyzed. Linear mixed effect models (LMEM) assessed individual MLVI change trajectories and predictors of growth, exploring both linear and curvilinear growth patterns posttransplant.ResultsA sample of 181 patients with at least 4 years of MLVI data were analyzed. Growth curve modeling identified the cubic model as the best fit for the quarterly MLVI values, which significantly decreased within the first 2 years posttransplant before stabilizing. Gender significantly predicted MLVI change, with females showing greater MLVI decreases, while age at transplant did not significantly predict changes. Significant variation in MLVI among individual patients was found in all models.ConclusionsThe study demonstrated a significant decrease in MLVI values over time, indicating improved medication adherence in pediatric transplant patients, with females exhibiting more adherent growth patterns than males. Future research should aim to identify pediatric patients at high risk of nonadherence. 10.1111/ctr.15442 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| doi_str_mv | 10.1111/ctr.15442 |
| format | Artículo Open Access |
| id | wiley_oa_10_1111_ctr_15442 |
| institution | Wiley Open Access |
| license_str_mv | http://onlinelibrary.wiley.com/termsAndConditions#vor |
| publishDate | 2024 |
| publisher | Wiley |
| record_format | wiley_oa |
| spellingShingle | Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients Michael O. Killian Callie W. Little Sonnie E. Mayewski Clinical Transplantation Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients Michael O. Killian Callie W. Little Sonnie E. Mayewski Clinical Transplantation ABSTRACTIntroductionLimited research has explored immunosuppressant medication adherence over time in pediatric transplant patients, who often struggle with posttransplant regimen adherence, resulting in poor outcomes.MethodsThis study investigated the longitudinal growth in immunosuppressive medication levels following transplantation. Medication level variability index (MLVI) scores from tacrolimus blood levels of pediatric organ transplant recipients at a major medical center were analyzed. Linear mixed effect models (LMEM) assessed individual MLVI change trajectories and predictors of growth, exploring both linear and curvilinear growth patterns posttransplant.ResultsA sample of 181 patients with at least 4 years of MLVI data were analyzed. Growth curve modeling identified the cubic model as the best fit for the quarterly MLVI values, which significantly decreased within the first 2 years posttransplant before stabilizing. Gender significantly predicted MLVI change, with females showing greater MLVI decreases, while age at transplant did not significantly predict changes. Significant variation in MLVI among individual patients was found in all models.ConclusionsThe study demonstrated a significant decrease in MLVI values over time, indicating improved medication adherence in pediatric transplant patients, with females exhibiting more adherent growth patterns than males. Future research should aim to identify pediatric patients at high risk of nonadherence. 10.1111/ctr.15442 http://onlinelibrary.wiley.com/termsAndConditions#vor |
| title | Changes in Medication Adherence Across the Posttransplant Period in Pediatric Organ Transplant Recipients |
| topic | Clinical Transplantation |
| url | https://onlinelibrary.wiley.com/doi/10.1111/ctr.15442 |